BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16549334)

  • 21. [Postoperative adjuvant treatment for pancreatic cancer: present status and future perspective].
    Uesaka K; Kanemoto H; Sugiura T; Mizuno T; Okamura Y; Kinugasa Y; Bando E; Terashima M
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1403-5. PubMed ID: 21918335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
    Eifel PJ
    Nat Clin Pract Oncol; 2006 May; 3(5):248-55. PubMed ID: 16683003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.
    Liu TS; Wang Y; Chen SY; Sun YH
    Eur J Surg Oncol; 2008 Nov; 34(11):1208-16. PubMed ID: 18353606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
    Butturini G; Stocken DD; Wente MN; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Dervenis C; Bassi C; Büchler MW; Neoptolemos JP;
    Arch Surg; 2008 Jan; 143(1):75-83; discussion 83. PubMed ID: 18209156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
    Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
    Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of meta-analysis of survival benefit when deciding treatment of adjuvant chemotherapy in gastric cancer.
    Kim R; Toge T
    Anticancer Res; 2003; 23(2C):1843-6. PubMed ID: 12820467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).
    Corsini MM; Miller RC; Haddock MG; Donohue JH; Farnell MB; Nagorney DM; Jatoi A; McWilliams RR; Kim GP; Bhatia S; Iott MJ; Gunderson LL
    J Clin Oncol; 2008 Jul; 26(21):3511-6. PubMed ID: 18640932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Old and new drugs in systemic therapy of pancreatic cancer.
    Pasetto LM; Jirillo A; Stefani M; Monfardini S
    Crit Rev Oncol Hematol; 2004 Feb; 49(2):135-51. PubMed ID: 15012974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress.
    Wolff RA; Varadhachary GR; Evans DB
    Ann Surg Oncol; 2008 Oct; 15(10):2773-86. PubMed ID: 18612703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative chemoradiation for pancreatic cancer.
    Evans DB
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S25-9. PubMed ID: 16399426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical and medical therapy for pancreatic carcinoma.
    Magee CJ; Ghaneh P; Neoptolemos JP
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):435-55. PubMed ID: 12079268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
    Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
    J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy for non-small cell lung cancer.
    Solomon B; Bunn PA
    Cancer Invest; 2007 Jun; 25(4):217-25. PubMed ID: 17612931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and controversies of adjuvant therapy for pancreatic cancer.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):121-5. PubMed ID: 18397844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer.
    Hayashibe A; Kameyama M; Shinbo M; Makimoto S
    Ann Surg Oncol; 2007 Jan; 14(1):190-4. PubMed ID: 17066232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cancer: current and future treatment strategies.
    Pliarchopoulou K; Pectasides D
    Cancer Treat Rev; 2009 Aug; 35(5):431-6. PubMed ID: 19328630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
    Kretzschmar A; Schlag PM
    Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.